Karyopharm Therapeutics logo

Karyopharm Therapeutics

A pharmaceutical company that develops drugs to treat cancer and other major disease

3

Funding Rounds

$88.2m

Money raised

Overview

A pharmaceutical company that develops drugs to treat cancer and other major disease

Funding

Funding series

Funding Series Analysis

The company Karyopharm Therapeutics has raised a total of $88.2m in funding over 3 rounds.

Key Insights:

  • Karyopharm Therapeutics Series B round: $48.2m
  • Karyopharm Therapeutics funding round, January 2013: $20m
  • Karyopharm Therapeutics Series A round: $20m
Karyopharm Therapeutics logo
Karyopharm Therapeutics Series B round $48.2m
Karyopharm Therapeutics logo
Karyopharm Therapeutics funding round, January 2013 $20m
Karyopharm Therapeutics logo
Karyopharm Therapeutics Series A round $20m

Industries

Karyopharm Therapeutics is active in the following industries:
  • Biomedical engineering
  • Healthcare
  • Therapeutics
  • Drug discovery
  • Oncology
  • Therapy
  • Cancer
  • Technology
  • Biology
  • Biotechnology
  • Internal medicine
  • Medicine
  • Multiple myeloma
  • Engineering